BNHLF Stock UPDATES Bioniche Life Scienc (BNHLF) 0.2134 09/11/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bioniche Life Scienc (BNHLF) 0.2134 $BNHLF

IIROC Trade Resumption - Bioniche Life Sciences Inc.
Newsfile Corp - Fri Aug 22, 1:12PM CDT
Trading resumes in:

IIROC Trade Halt - Bioniche Life Sciences Inc.
Newsfile Corp - Thu Aug 21, 2:29PM CDT
The following issues have been halted by IIROC:

Bioniche Announces Q1/2015 Timeline for the Filing of a Biologics License Application for Marketing Approval of MCNA in the United States
PR Newswire - Tue Aug 19, 7:00AM CDT
Bioniche Life Sciences Inc. (TSX: BNC) today announced that it is targeting Q1/2015 for the filing of a Biologics License Application (BLA) with the United States Food and Drug Administration (FDA) for Bioniche's lead program Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) for the treatment of patients with high grade non-muscle invasive bladder cancer that have failed Bacillus Calmette-Guérin (BCG) therapy. This projected timeline integrates the conclusions of a regulatory gap analysis prepared by its consultants (reviewing the state of each BLA module and estimating the time to complete) with the planning and scheduling of a pre-BLA meeting between Bioniche and the FDA prior to the BLA filing.

Bioniche Announces Submission of Orphan Drug Designation Application for MCNA in the United States
PR Newswire - Tue Jul 29, 7:00AM CDT
Bioniche Life Sciences Inc. (TSX: BNC) today announced the submission to the US Food and Drug Administration (FDA) Office of Orphan Products Development, an application for Orphan Drug Designation for its Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) sterile suspension for the treatment of patients with Bacillus Calmette-Guérin (BCG) refractory/relapsing high grade non-muscle invasive bladder cancer.

Bioniche Announces Intention to File for Marketing Approval of MCNA in the United States
PR Newswire - Fri Jul 18, 7:00AM CDT
Bioniche Life Sciences Inc. (TSX: BNC) today provided a key regulatory update on its flagship Phase 3 program, Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) sterile suspension for the treatment of patients with Bacillus Calmette-Guérin (BCG) refractory high grade non-muscle invasive bladder cancer.

Global Animal Growth Promoters and Performance Enhancers Market Report 2014-2018
M2 - Fri Jul 11, 2:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4drwgt/animal_growth) has announced the addition of the "Global Animal Growth Promoters and Performance Enhancers Market Report 2014-2018" report to their offering. Antibiotics was the largest segment of the animal growth promoters market and was valued at $4,489.7 million in 2013 However, feed enzymes are expected to grow at the fastest rate owing to the increasing popularity and demand for alternatives to antibiotic and hormonal growth promoters. The animal growth promoters and performance enhancers market is segmented into antibiotics/antimicrobials, probiotics and prebiotics, organic acids, feed enzymes, hormonal growth promonants, ?-agonists, phytogenics, and others. These growth promoters are used in the animal feed to increase their growth and to enhance their performance. The animal growth promoters and performance enhancers market, by animal industry is segmented into porcine, poultry, livestock, equine, and aquaculture. The porcine industry made use of the largest amount of growth promoters, in 2013, followed by poultry and livestock. The changing consumption trend globally is likely to increase the demand for pork meat, thus making more use of the growth promoters. Countries such as Brazil, Australia, and New Zealand in the RoW region are also expected to witness growth in this market, owing to very little regulations on the use of growth promoters in animals and the increasing meat demand. The global animal growth promoters and performance enhancers market witness's high competitive intensity as there are many big and small firms with similar product offerings. These companies adopt various strategies to increase their market share and to establish a strong foothold in the global market. However, increasing awareness amongst consumers regarding the hazards of using antibiotic growth promoters and their ban are likely to hamper the growth of this market. The report extensively covers the animal growth promoters and performance enhancers market (products and animals). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Animal Performance Enhancers Market, By Product 5 Global Animal Performance Enhancers Market, By Animal 6 Geographic Analysis 7 Competitive Landscape 8 Company Profiles - Bayer Animal Health (A Subsidiary of Bayer Ag) - Biomin Holding Gmbh - Bioniche Animal Health (A Division of Bioniche Life Sciences, Inc.) - Boehringer Ingelheim - Bupo Animal Health (PTY) - Cargill, Inc. - Elanco Animal Health (A Division of Eli Lilly and Company) - Merck Animal Health (A Subsidiary of Merck & Co., Inc.) - Royal Dsm N.V. - Zoetis, Inc. For more information visit http://www.researchandmarkets.com/research/4d...mal_growth

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2014
M2 - Mon Jun 16, 6:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n696j4/non_muscle) has announced the addition of the "Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) and special features on late-stage and discontinued projects. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Scope - The report provides a snapshot of the global therapeutic landscape of Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) and enlists all their major and minor projects Companies Mentioned: - Bioniche Life Sciences - TARIS BioMedical - Spectrum Pharmaceuticals. - Altor BioScience - Telormedix - Heat Biologics - Viventia Biotechnologies - Cold Genesys - Laurantis Pharma For more information visit http://www.researchandmarkets.com/research/n696j4/non_muscle

Bioniche Life Sciences Inc. to Present at Bloom Burton & Co. Healthcare Investor Conference
PR Newswire - Fri Jun 13, 8:06AM CDT
Bioniche Life Sciences Inc. (TSX: BNC) - ("Bioniche" or the "Company" , a clinical stage biotechnology company whose anchor product is a Phase III treatment for non-muscle-invasive bladder cancer, today announced that Dr. Michael Berendt, Chief Executive Officer and Chief Scientist of Bioniche Life Sciences Inc., will present a corporate update at the Bloom Burton & Co. Healthcare Investor Conference at the Toronto Board of Trade on June 18, 2014 at 3:30 P.M. EDT in Toronto. Bioniche's corporate presentation will be available on the Company's website at www.bioniche.com following the presentation.

Bioniche Life Sciences Inc. Holds Shareholder Conference Call/Webcast
PR Newswire - Thu Mar 13, 5:06PM CDT
Bioniche Life Sciences Inc. (TSX: BNC) today held a conference call and audio webcast for its shareholders, at which time, Company representatives provided several corporate updates. The corporate presentation used during today's call/webcast is available on the Company's website (www.Bioniche.com) under Investors - Corporate Presentations.

Bioniche Life Sciences Inc. Announces Key Corporate Updates
PR Newswire - Tue Mar 04, 8:00AM CST
Bioniche Life Sciences Inc. (TSX: BNC) announced today key corporate updates:

Vétoquinol to Acquire the Animal Health Business of Bioniche Life Sciences Inc.
PR Newswire - Thu Feb 27, 3:58PM CST
Vétoquinol (NYSE Euronext Paris: VETO) and Bioniche Life Sciences Inc. (TSX: BNC), today jointly announced their signing of a share purchase agreement under which Vétoquinol has agreed to purchase Bioniche's Animal Health business for the cash purchase price of CAD$61 million. This agreement remains subject to the approval by shareholders of Bioniche Life Sciences Inc., and the usual closing conditions for a transaction of this type. The Boards of Directors of both corporations have approved the binding agreement, and notice of a special Bioniche shareholder meeting will be forthcoming.

Bioniche Life Sciences Inc. Reports Fiscal 2014 Second Quarter Results and Announces Strategic Expenditure Review and New One Health Strategy
PR Newswire - Thu Feb 06, 11:47AM CST
(all figures are in Canadian dollars unless otherwise noted)

Bioniche Life Sciences Inc. Appoints a Chief Operating Officer
PR Newswire - Tue Jan 07, 4:00PM CST
Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a leading clinical stage biotechnology company, today announced the appointment of Donald Olds as Chief Operating Officer, effective immediately.

Bioniche Life Sciences Inc. and Concerned Shareholders Announce a Settlement
PR Newswire - Wed Sep 11, 1:13PM CDT
new Board to oversee sale of Animal Health and sale/partnering of VMC with commitment to return capital to shareholders -




Scroll down for more posts ▼

Top 10 Most Recent News Articles

RingConn Bets Middle-earth Fandom Can Boost Health Wearables

Updated Category News Views 102

A Familiar Gold Band Meets a Crowded Wearables Market RingConn has taken one of pop culture's most loaded objects and turned it into a health-tracking accessory, which is either clever brand work or a costly bit of cosplay depending on execution. The company unveiled The One Ring, a limited-edition version of its Gen 3 Smart Ring, through a partnership with Warner Bros....

Continue Reading
GEYOTO’s RE+ Debut Shows Demand, Not Yet Scale Proof

Updated Category News Views 39

Desert-colored booths do not pay invoices, but a nearly sold-out stash of spare units is a lot more useful than the usual trade-show applause. GEYOTO’s first RE+ appearance, held November 17–19 at the Las Vegas Convention Center, produced the kind of early evidence a young energy-products brand needs: people stopped, handled the equipment, asked questions, made...

Continue Reading
Workers Are Burning Savings as Pay Falls Behind Costs

Updated Category News Views 69

Payroll optimism has been ground into dust by the ordinary bills nobody can dodge. Monster's 2026 Cost of Living Report says 93% of employed U.S. workers feel their wages are failing to keep up with costs, barely different from 95% in both 2024 and 2025. That is not a blip, and it is not workers merely grousing about prices. Three years of nearly identical frustration...

Continue Reading
Mars Sets $2 Billion Debt Tender With Kellanova Notes

Updated Category News Views 108

A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...

Continue Reading
Central Florida Buyers Face the Cash Reality First

Updated Category News Views 109

A house hunt can go sideways before the first showing if the buyer has confused a dream budget with a real one. Tom McKnight’s guidance for first-time buyers in Central Florida lands on the unglamorous stuff, which is exactly where it ought to land: cash, credit, financing, insurance, taxes, and the physical condition of the house. Nobody enjoys staring at lender...

Continue Reading
CVRx Lawsuit Puts Barostim Sales Claims Under Hard Scrutiny

Updated Category News Views 109

August 7 turned a compliance disclosure into a wrecking ball for CVRx shareholders. After the company revealed a Department of Justice civil investigative demand and cut its outlook, the stock dropped $3.55, or 60%, to close at $2.39. That is not a routine bad quarter getting punished. It is the market abruptly questioning whether the sales engine, the revenue it...

Continue Reading
KONST Pitches Asia GPU Uptime as AI Demand Gets Real

Updated Category News Views 115

GPU racks are easy to admire when the lights are on; keeping them useful at 3 a.m. is where the bruises show. KONST arrived at SC26 in Chicago with a sensible pitch for an AI-infrastructure market that is getting less impressed by shiny hardware lists and more obsessed with whether the thing actually works. Its theme, “24/7 GPUs Delivered in Asia,” puts the emphasis...

Continue Reading
Why Brief Chiropractic Visits Still Need Clear Expectations

Updated Category News Views 97

A few minutes on the table can sound almost suspiciously brisk when somebody is dealing with a stiff neck, sore back, or nagging joint discomfort. Yet that is the central point in Dr. Craig Peterson's explanation for HelloNation: the adjustment itself may be brief, while the value of a chiropractor visit depends on a focused assessment, appropriate technique, and whether...

Continue Reading
PayPal's New Leadership Map Puts Execution on Trial

Updated Category News Views 106

Four senior appointments and a risk-chief exit can turn a tidy strategy slide into a very real operating test. PayPal has spent months defining three-year plans, simplifying its operating model and assigning clearer accountability; on November 20, it put names beside the jobs. For NASDAQ:PYPL investors, that is more consequential than another broad promise about...

Continue Reading
CVRx Lawsuit Puts a Hard Date on Investor Decisions

Updated Category News Views 65

One ugly filing after the bell can vaporize years of shareholder confidence, and CVRx just supplied the painful exhibit. On August 7, 2026, shares of CVRx fell $3.55, or 59.76%, to close at $2.39 after the company disclosed a U.S. Department of Justice civil investigative demand in its August 6 Form 10-Q. That is not a routine bad quarter. It is the sort of disclosure...

Continue Reading

Top 5 Most Recently Viewed Articles

Arcline Investment Management Sells Resolution Medical to Resonetics

Updated Category News Views 213

Arcline Investment Management Sells Resolution Medical Arcline Investment Management, a dynamic private equity firm, has made a notable move in the medical technology landscape. The firm is set to sell its portfolio company, Resolution Medical, to Resonetics. This strategic decision highlights Arcline's ongoing commitment to advancing innovative solutions within the...

Continue Reading
Cheetah Mobile Surges with Impressive Q2 Financial Results

Updated Category News Views 223

Cheetah Mobile Reports Strong Growth in Q2 2025 Cheetah Mobile Inc. (NYSE: CMCM), a prominent IT company, has recently reported its financial results for the second quarter of 2025. The results indicate a remarkable increase in total revenue and profitability, showcasing the company’s ongoing strategic transformation. Management Insights on Performance Mr. Sheng Fu,...

Continue Reading
OwlTing Group Launches OwlPay Harbor for Enhanced Payment Solutions

Updated Category News Views 287

OwlTing Group Transforms Payments with AI-Powered OwlPay Harbor OwlTing Group, a pioneering blockchain fintech firm, has announced a significant evolution of its payment platform, OwlPay Harbor. This innovative service integrates artificial intelligence to enhance the experience for developers and users alike, making financial transactions faster and more secure than ever...

Continue Reading
Colt DCS Taps Nguyen for CEO Amid Growth Surge

Updated Category News Views 24

Nguyen Takes Helm at Colt DCS Well, here's a move that'll definitely shake the data center landscape a bit: Quy Nguyen's stepping up as the Chief Executive Officer at Colt Data Centre Services. From temporary to permanent, that decision speaks volumes about the trust in his leadership acumen during these transformative times. Colt's apparently betting the farm on Nguyen...

Continue Reading
NWR Storage Containers Expands with New Facility Opening

Updated Category News Views 143

NWR Storage Containers Expands with New Facility Opening NWR Storage Containers, a prominent provider of storage container rentals, is excited to announce its relocation to a larger facility. This event marks a significant step forward in their journey of growth and commitment to serving customers effectively. Relocation to a New Facility The newly established operations...

Continue Reading